| BIOFRONTERA AG NA O.N. |
| Deutschland |
| Gesundheit |
| DE000A4BGGM7 / A4BGGM |
| B8FK (Frankfurt) |
| FRA:B8FK, ETR:B8FK, B8FK:GR |
| - |
| https://www.biofrontera.c.. |
|
Biofrontera AG is a biopharmaceutical company specializing in the development, research, and commercialization of dermatological drugs, with a strong emphasis on photodynamic therapy (PDT) for skin co..
>Volltext.. |
| 14.77 Mio. EUR |
| 11.84 Mio. EUR |
| 22.99 Mio. EUR |
| 0.62 Mio. EUR |
| -2.11 Mio. EUR |
| -0.35 EUR |
| 0.53 Mio. EUR |
| 3.42 Mio. EUR |
| - |
| 0.69 |
| 27.97% |
| -497.21% |
| - |
| - |
| - |
| - |
| BIOFRONTERA |
| 17.02.26 |
|